Munafa Stock Market Course + Intraday & FNO calls 
NATCOPHARM NEWS why is Natco Pharma Limited price falling or rising
NATCOPHARM NEWS reasons for why stock price of Natco Pharma Limited is falling or rising
NATCOPHARM Natco Pharma is falling or rising technical reasons
Technical analysis forecast for Natco Pharma Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Natco Pharma NATCOPHARM at this time. Stock is falling and might fall more.
It appears as if Natco Pharma NATCOPHARM gave a large move recently.
Stock of Natco Pharma (NATCOPHARM) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
Although my analysis for Natco Pharma is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 887.2, for a target of 906.1 or 921.86
NATCOPHARM Natco Pharma is falling or rising NEWS fundamental reasons
Company Announcement Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication for the Un-Audited Financial Results for the quarter ended June 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27. - NEWS as on 2026-08-17
NATCOPHARM announced a dividend of Rupees 1.50 per share, which makes a dividend yield of 0.17 based on current price. Effective date of this dividend is 20 Thu Aug 2026 - NEWS as on 2026-08-17 MunafaSutra.com
Company Announcement Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27 - NEWS as on 2026-08-14
Natco Pharma Q1 results: Profit falls 57% to ?206 cr, revenue at ?735 cr Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net pro - NEWS as on 2026-08-14 business-standard.com
Board Meeting to discuss Fund Raising To consider Fund Raising - NEWS as on 2026-08-12
Company Announcement - NEWS as on 2026-08-12
Board Meeting to discuss Financial Results/Dividend To consider and approve the financial results for the period ended Jun 30, 2026 and declare interim dividend, if any for the FY 2026-27 - NEWS as on 2026-08-07
More announcements and NEWS
NATCOPHARM Natco Pharma Limited current price & indicator signals
Recent prices of NATCOPHARM Natco Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 17 Mon Aug 2026 | 889.80 | 870.20 to 897.10 | -1.48% | 1.46 times |
| 14 Fri Aug 2026 | 903.15 | 886.35 to 964.85 | -5.1% | 4.31 times |
| 13 Thu Aug 2026 | 951.70 | 917.20 to 962.00 | 3.98% | 2.07 times |
| 12 Wed Aug 2026 | 915.30 | 906.00 to 922.15 | 0.92% | 0.47 times |
| 11 Tue Aug 2026 | 907.00 | 903.25 to 928.90 | -0.38% | 0.7 times |
| 10 Mon Aug 2026 | 910.50 | 905.60 to 932.50 | -0.67% | 0.34 times |
| 07 Fri Aug 2026 | 916.65 | 911.00 to 919.25 | 0.45% | 0.29 times |
| 06 Thu Aug 2026 | 912.50 | 910.00 to 932.00 | -0.55% | 0.36 times |
| 05 Wed Aug 2026 | 917.55 | 912.10 to 925.50 | 0.06% | 0.41 times |
| 04 Tue Aug 2026 | 917.00 | 912.00 to 931.45 | -1.3% | 0.55 times |
| 03 Mon Aug 2026 | 929.10 | 918.10 to 939.85 | 1.32% | 0.5 times |
| 31 Fri Jul 2026 | 917.00 | 913.00 to 935.65 | -1.38% | 0.57 times |
Videos related to: NATCOPHARM NEWS why is Natco Pharma Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
